Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...
The liver releases small amounts of C-reactive protein (CRP) to fight infections and inflammation. However, high C-reactive protein levels indicate significant inflammation caused by a health ...
CNBC Select will update as changes are made public. With a high-yield savings account, you can get a solid interest rate and your money grows even faster thanks to compound interest — which lets ...
That’s how I ended up in a phlebotomist’s chair at Quest Diagnostics at 7 a.m. on a recent Saturday, looking hard in the ...
Are you tired of feeling sluggish and bloated after your meals? Are you frustrated by the continual discomfort caused by ...
Growth in the brewing enzymes market is attributed to the rising demand for beer and alcoholic drinks, which has led to ...
Confused about eating soaked and unsoaked almonds? Although rich in multiple nutrients, almonds have always sparked a debate ...
AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...
We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn and work.
AstraZeneca's supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive ...
Am J Health Syst Pharm. 2008;65(24):2347-2357. Crush one pancrelipase tablet (lipase 8000 units, amylase 30,000 units, protease 30,000 units) to a fine powder, or measure one fourth of a teaspoon ...
Despite the high unmet need generally perceived in rare diseases, the number of unfavourable ASMR ratings (i.e., ASMR 4 or ASMR 5) illustrates the challenges for drug manufacturers in providing ...